DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Suparnostic
Suparnostic
Proposal for Assessment of New Health Technologies
Virogates Has Been Granted a New Patent to Measure the Risk of Developing Life Style Related Diseases Using Its Suparnostic ® Biomarker Product
Novel Biomarkers in the Management of HPV-Positive & -Negative Oropharyngeal Carcinoma January 2016
See Virogates Presentation Here
Of Body Inflammation for Maxillofacial Surgery Purpose-To Make
Plasma Levels of the Active Form of Supar Are Associated with COVID
Virogates A/S Investor Presentation 16 June 2020 Danske Bank, Copenhagen Virogates
Virogates Appoints Dr
Supar As a Biomarker for Risk of Readmission and Mortality in the Acute Medical Setting
PRESS RELEASE 1 May 2020
Immunosenescence of the CD8+ T Cell Compartment Is Associated With
ISA2018 Abstract Volaume
Sepsis Diagnostic Methods and Protocols M ETHODS in MOLECULAR BIOLOGY
Correlates for Disease Progression and Prognosis During Concurrent HIV/TB Infection
Supar As a Prognostic Biomarker in Sepsis Katia Donadello, Sabino Scolletta, Cecilia Covajes and Jean-Louis Vincent*
Assessment of Simple Risk Markers for Early Mortality Among HIV-Infected Patients in Guinea-Bissau: a Cohort Study
Role of Soluble Urokinase Plasminogen Activator Receptor (Supar) As Prognosis Markers of Neonatal Sepsis
The Role of Circulating Biomarkers, Genetics, and Diet in Kidney Function
Top View
Analytical, Biochemical and Clearance Considerations of Soluble Urokinase Plasminogen Activator Receptor (Supar) in Healthy Indi
Diagnostic and Prognostic Value of Soluble Urokinase-Type
Virogates Announces Initiation of a Clinical Trial with HISS to Clinically
Soluble Urokinase Receptor (Supar) in COVID-19–Related AKI
Clinical Chemistry and Laboratory Medicine (CCLM)
Sepsis 2008 Granada, Spain, 19-22 November 2008
EDCTP Portfolio Clinical Trials and Integrated Projects
Does Soluble Urokinase-Type Plasminogen Activator Receptor Level Predicts the Occurrence of Inflammatory Complications in Maxillofacial Surgery?
From DEPARTMENT of CLINICAL SCIENCE and EDUCATION, SÖDERSJUKHUSET Karolinska Institutet, Stockholm, Sweden
(1 → 3)-Β-D-Glucan and Supar Levels Correlate with Neurocognitive Performance in People Living with HIV on Antiretroviral Therapy: a CHARTER Analysis
Triage for Alf Reader to Give a Quantitative Measurement of the Plasma Supar Ng/Ml)2
20210126-Virogates Company Announcement 2.Pdf
Soluble Urokinase Plasminogen Activator Receptor As a Marker for Use of Antidepressants
Supar Correlates with Mortality and Clinical Severity in Patients
Study Protocol and Statistical Analysis Plan
Soluble Urokinase-Type Plasminogen Activator Receptor (Supar) – a Possible Biomarker for Bacteremia in Sepsis
20131109 Kit Insert 2013
Neutrophils Are a Main Source of Circulating Supar Predicting